Is Corin going to be swallowed up?
Hip-replacement specialist Corin was mentioned as another bid target, possibly for Smith and Nephew. The cue for the bid chatter was the end of a distribution agreement Corin had with S&N rival Stryker. Smith and Nephew shares were unchanged at 654p, while Corin was up 0.5p to 56p.
- Stryker cuts ties with Corin Group amid two new distribution deals (medcitynews.com)
- Smith & Nephew turns attention to emerging economies to counteract tough European market (independent.co.uk)
- Orthopaedics: Market Prospects & Global Competition Share (earlsview.com)
- Is Stryker the Right Stock to Retire With? (fool.com)